Next Article in Journal
Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy
Next Article in Special Issue
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Previous Article in Journal
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice
Previous Article in Special Issue
Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis
 
 
Case Report

Article Versions Notes

Curr. Oncol. 2022, 29(10), 6787-6793; https://doi.org/10.3390/curroncol29100534
Action Date Notes Link
article xml file uploaded 22 September 2022 10:55 CEST Original file -
article xml uploaded. 22 September 2022 10:55 CEST Update https://www.mdpi.com/1718-7729/29/10/534/xml
article pdf uploaded. 22 September 2022 10:55 CEST Version of Record https://www.mdpi.com/1718-7729/29/10/534/pdf
article html file updated 22 September 2022 10:57 CEST Original file https://www.mdpi.com/1718-7729/29/10/534/html
Back to TopTop